Q-absorb supplementation may improve cardiac function in heart failure patients.

The results of a clinical trial investigating the effects of Jarrow Formulas' (Los Angeles, CA) Q-absorb, an enhanced-absorption CoQ 10 formula, on chronic heart failure patients was recently published in the European Heart Journal. Italian scientists from the Lancisi Heart Institute and the University of Ancona (Institute of Biochemistry) measured the effects of 300 mg per day (100 mg T.I.D.) Q-absorb on the cardiovascular functional capacity of 23 heart patients. Measurements included endothelial-dependent vasodilatation as measured by ultrasound BART (brachial artery reactivity test), plasma ubiquinone, and other important cardiovascular biochemical parameters.

In this randomized, placebo-controlled, double-blind, crossover clinical trial, the study results proved the efficacy of Q-absorb, as demonstrated by improving functional capacity (peak volume of oxygen consumed VO2); improvement in endothelial-dependent vasodilatation; and tripling of plasma coenzyme Q 10 levels.